PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 29, 2025Cancer Research0 citations

Abstract B110: High-dimensional spatial analysis of murine PDAC microenvironment emphasizes primary and metastatic immune heterogeneity

View Full Paper
CLChristina R. LarsonSASatwik AcharyyaJBJoel Baines

Key Points

  • Immune infiltration patterns differ significantly between primary and metastatic tumor sites in PDAC.
  • Using a novel 46-marker immunofluorescent staining panel, distinct immune cell populations were quantified.
  • The study analyzed matched murine PDAC samples from different cell lines and demonstrated inter-tumoral heterogeneity.
  • These findings underscore the complexities of PDAC and may inform future mechanistic studies targeting its TME.

Abstract

Abstract Heterogeneity within the pancreatic ductal adenocarcinoma (PDAC) tumor microenvironment (TME), across tumor locations, and between patients largely contributes to poor treatment response and PDAC’s status as the fourth leading cause of cancer death in the United States. In order to identify suitable targets for innovative therapeutic interventions, it is necessary to understand and mechanistically test TME constituents, their infiltration, and their interaction dynamics in the context of primary and metastatic tumor locations using pre-clinical modeling. Therefore, we designed a novel 46-marker multiplex immunofluorescent staining panel for murine formalin-fixed paraffin-embedded (FFPE) tissues. This panel enables the spatial quantification of immune cell populations and activation/exhaustion states, epithelial-to-mesenchymal phenotypes, cancer-associated fibroblast heterogeneity, hematologic and lymphatic vessel infiltration, neuronal infiltration, and extracellular matrix deposition in the TME. We quantified the composition and spatial infiltration of the TME on matched murine primary and liver tumor samples from tandem orthotopic and hemi-spleen transplants of three distinct primary murine PDAC cell lines derived from the KPC model (KrasG12D; TP53R172H; PDX1-Cre; RosaEYFP). The resulting primary tumors from each cell line showed inter-tumoral heterogeneity as their distinct levels of immune infiltration had varying clustering patterns. Spatial analysis further revealed heterogeneous cancer cell MHC-I expression, immune cell exhaustion, and myeloid and lymphoid populations correlating with cell line. However, all liver nodules were encased by a barrier of immune cells separating the tumor from normal liver parenchyma irrespective of cell line. This observation reflects our recent spatial transcriptomic analysis of patient-derived matched liver and primary tumors, supporting the use of these pre-clinical models for future mechanistic investigations. Altogether, these data highlight the complexity of PDAC TMEs and the site-specific differences between primary and metastatic tumor composition. Citation Format: Christina R. Larson, Satwik Acharyya, Jace Baines, Ayushi Mandloi, Robert Welner, Julienne L. Carstens. High-dimensional spatial analysis of murine PDAC microenvironment emphasizes primary and metastatic immune heterogeneity abstract. In: Proceedings of the AACR Special Conference in Cancer Research: Advances in Pancreatic Cancer Research—Emerging Science Driving Transformative Solutions; Boston, MA; 2025 Sep 28-Oct 1; Boston, MA. Philadelphia (PA): AACR; Cancer Res 2025;85 (18Suppl₃): Abstract nr B110.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Larson et al. (2025) studied this question.

synapsesocial.com/papers/68da58dcc1728099cfd113a2https://doi.org/10.1158/1538-7445.pancreatic25-b110
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Abstract B115: Integrated spatial and multi-omic analysis reveals functional niches in the pancreatic cancer microenvironment2025
  2. 2Abstract B126: Single-cell and spatially resolved atlas of pancreatic cancer reveals immunophenotypes associated with clinical outcome2025
  3. 3Abstract 3988: Deep spatial immunophenotyping of lymphoid aggregates in pancreatic cancer using multi-omic integration of ultra high-plex proteomics and transcriptomics2024
  4. 4Abstract B128: Spatial proteomics extend tumour subtype and microenvironment classifications across genotype-phenotype axes of pancreatic cancer2025
  5. 5Abstract A084: Dynamics of tumor immune environment across organs in early and late-stage metastatic pancreatic cancer2025